Clinical Trial Update: SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors [Phase 1]

View source ↗

Summary

The SJDAWN Phase 1 trial at St. Jude evaluated molecularly-driven doublet therapies for children and young adults with recurrent brain tumors. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Embryonal Tumor with Multilayered Rosettes
• Ependymoma
• Glioblastoma
• Medulloblastoma
• Oligodendroglioma
• Pineoblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 1 | Status: COMPLETED